在严重喘中对生物治疗的长期反应的评估和治疗调整的考虑
Jordan Giordani1, Alessandro Pini2, Laura Pini1,3
1Department of Clinical and Experimental Sciences, University of Brescia, 25123 Brescia, Italy.
Journal of clinical medicine
|April 26, 2025
概括
了解严重喘生物治疗的长期反应是关键. 这项研究有助于优化患者管理和改善临床结果,以更好地控制喘.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 重症喘管理需要评估长期治疗的疗效.
- 生物疗法为治疗严重喘提供了新的途径.
- 优化患者护理需要了解治疗的耐用性和影响.
研究的目的:
- 评估严重喘中生物疗法的长期有效性和安全性.
- 确定对生物治疗持续反应的预测因素.
- 为严重喘提供个性化医疗方法的证据.
主要方法:
- 纵向队列研究的设计.
- 分析临床数据,包括肺功能,恶化率和生活质量.
- 生物标志物分析与治疗反应相关联.
主要成果:
- 在很大一部分患者中观察到持续改善肺功能和减少恶化.
- 长期反应的可变性被注意到,一些患者经历了随着时间的推移效率下降.
- 特定的生物标志物显示出预测持续反应的潜力.
结论:
- 生物疗法可以为许多严重喘患者提供持久的益处.
- 长期监测对于管理治疗有效性和潜在衰退至关重要.
- 对预测生物标志物的进一步研究可以指导个性化治疗策略.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K
COPD: Management Using Bronchodilators and Corticosteroids
122
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
122
Drugs Used in Lower Respiratory Disorders: Overview
244
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
244
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
156
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
156
Antiasthma Drugs: β2-Adrenoceptor Agonists
147
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
147


